Search results for "Cardiology"

showing 10 items of 6064 documents

Radiation exposure in vascular angiographic procedures.

2012

Abstract Purpose To evaluate dose reduction in vascular angiographic procedures by using fluoroscopy capture instead of digital subtraction angiography frames for documentation. Materials and Methods A total of 764 consecutive vascular interventional procedures performed over a period of 1 year were retrospectively analyzed with respect to the fluoroscopy time and the resulting dose–area product (DAP), the DAP of the radiographic frames, and the overall DAP. Results A total of 70% of the total DAP was a result of the acquisition of radiographic frames, leaving only 30% being applied by fluoroscopy. Conclusions Fluoroscopy capture should be used for documentation whenever possible. A registr…

medicine.medical_specialtyTime FactorsRadiographyHealth PersonnelRadiation DosageRadiography InterventionalRadiation ProtectionRadiation MonitoringOccupational ExposuremedicineFluoroscopyHumansRadiology Nuclear Medicine and imagingOccupational HealthRetrospective Studiesmedicine.diagnostic_testbusiness.industryAngiography Digital SubtractionDigital subtraction angiographyRadiation exposureDose area productFluoroscopyDose reductionRadiologyCardiology and Cardiovascular MedicinebusinessNuclear medicineJournal of vascular and interventional radiology : JVIR
researchProduct

Systemic pulsatile pressure in type II endoleaks after stent grafting of experimental abdominal aortic aneurysms.

2003

Purpose: To investigate pressure and maximum rate of rise of systolic pressure (peak dP/dt) in completely excluded aneurysms and endoleaks to determine the hemodynamic impact of endoleaks. Methods: In mongrel dogs (n = 36) experimental aneurysms were created by insertion of a patch (portion of rectus abdominis muscle sheath) into the infrarenal aorta. In group I (n = 18), all aortic branches of the aneurysm were ligated and all aneurysms were completely excluded by stent grafts. Group II (n = 18) consisted of aneurysms with patent aortic side branches that represented sources of endoleaks. One week (n = 12), six weeks (n = 12), and six months (n = 12) after stent grafting, hemodynamic measu…

medicine.medical_specialtyTime FactorsSystolemedicine.medical_treatmentDiastolePulsatile flowHemodynamicsCollateral CirculationBlood PressureAortic aneurysmBlood Vessel Prosthesis ImplantationAneurysmDogsPostoperative ComplicationsDiastoleInternal medicinemedicine.arteryMedicineAnimalsRadiology Nuclear Medicine and imagingAorta AbdominalAortabusiness.industryModels CardiovascularStentmedicine.diseaseDisease Models AnimalBlood pressurePulsatile Flowcardiovascular systemCardiologyStentsCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedAortic Aneurysm AbdominalFollow-Up StudiesCardiovascular and interventional radiology
researchProduct

Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Stud…

2013

Primary aldosteronism (PA) is the most common endocrine form of hypertension and may carry an increased risk of atrial flutter or fibrillation (AFF). The primary goal of this multicentre cohort study is thus to prospectively establish the prevalence of PA in consecutive hypertensive patients referred for lone (non-valvular), paroxysmal or permanent AFF. Secondary objectives are to determine: (1) the predictors of AFF in patients with PA; (2) the rate of AFF recurrence at follow-up after specific treatment in the patients with PA; (3) the effect of AFF that can increase atrial natriuretic peptide via the atrial stretch and thereby blunt aldosterone secretion, on the aldosterone-to-renin rati…

medicine.medical_specialtyTime FactorsTime FactorElectric CountershockPlasma renin activityaldosteronism; atrial fibrillation; high blood pressure; plasma reninPrimary aldosteronismRecurrenceInternal medicineatraial fibrillationReninHyperaldosteronismInternal MedicinePrevalenceMedicineHumansSinus rhythmatrial fibrillationprimary aldosteronism; hypertension; atraial fibrillationProspective StudiesProspective cohort studyAldosteroneFibrillationaldosteronismprimary aldosteronismChi-Square Distributionbusiness.industryAtrial fibrillationmedicine.diseaseHyperaldosteronismplasma reninEuropeProspective StudieTreatment OutcomeAtrial FlutterResearch DesignAnti-Arrhythmia AgentBiological MarkerHypertensionCardiologyQuality of Lifemedicine.symptombusinessAnti-Arrhythmia AgentsAtrial flutterBiomarkersHumanhigh blood pressure
researchProduct

Effect of Atrial Capture Beats on the Subsequent Cycle During Slow Common Atrioventricular Nodal Reentry Tachycardia

2013

medicine.medical_specialtyTime Factorsmedicine.diagnostic_testbusiness.industryCardiac anatomyAtrial arrhythmiasMiddle AgedNodal diseasePredictive Value of TestsPhysiology (medical)Predictive value of testsInternal medicineAtrial captureElectrocardiography AmbulatoryTachycardia SupraventricularmedicineCardiologyHumansTachycardia Atrioventricular Nodal ReentryTachycardia ParoxysmalCardiology and Cardiovascular MedicinebusinessElectrocardiographyJournal of Cardiovascular Electrophysiology
researchProduct

Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of …

2014

Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG). All consecutive women from the Drug-Eluting stent for LefT main coronary Artery disease registry with ULMCA disease were analyzed. A propensity matching was performed to adjust for baseline differences. In total, 817 women were included: 489 (59.8%) unde…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentCoronary AngiographySeverity of Illness IndexCoronary artery diseasePercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineHumansMyocardial infarctionRegistriesCoronary Artery BypassPropensity ScoreAgedRetrospective Studiesbusiness.industryCoronary StenosisPercutaneous coronary interventionStentDrug-Eluting StentsOdds ratiomedicine.diseaseCoronary VesselsSurgerymedicine.anatomical_structureTreatment OutcomeDrug-eluting stentConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryFollow-Up Studies
researchProduct

Coronary stent implantation in acute vessel closure 48 hours after an unsatisfactory coronary angioplasty

1990

We report the implantation of a balloon-expandable stent in a patient with acute vessel closure in the state of evolving myocardial infarction following 48 hr after unsatisfactory coronary angioplasty. The stent was implanted after successful recanalization of an occluded left anterior descending artery, with repeated unsatisfactory results of balloon angioplasty. Adjunct thrombolytic therapy was contraindicated. No residual stenosis was documented in immediate control angiograms, or after 24 hr, 3 weeks, and 4 months.

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentCoronary DiseaseCoronary AngiographyBalloonAngioplastyInternal medicineCoronary stentmedicineHumansAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon Coronarybusiness.industryStentResidual stenosisMiddle Agedmedicine.diseaseCoronary VesselsSurgerymedicine.anatomical_structureCardiologyStentsCardiology and Cardiovascular MedicineComplicationbusinessArteryCatheterization and Cardiovascular Diagnosis
researchProduct

Transverse Small Skin Incision for Carotid Endarterectomy

2015

The purpose of this report is to determine the feasibility of short transverse skin incision (STI4 cm) for eversion (EEA) and patch (PEA) endarterectomy with or without shunt by comparing it with the outcomes after long transverse skin incision (LTI 4-8 cm).Of 164 elective consecutive patients (71 ± 2.73% symptomatic) operated at one institution over 24 months, 81 were treated with STI, while 83 patients received LTI. The LTI and STI groups did not differ in terms of age, symptoms, or risk factors. EEA or PEA under locoregional (LRA) or general (GA) anesthesia were performed.STI was associated with shorter operation times (75.19 ± 15.33 vs. 94.87 ± 41 and 99.4 ± 27.36 vs. 132.66 ± 51.32, re…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentDermatologic Surgical ProceduresOperative TimeMedizinCarotid endarterectomyAnesthesia Generalurologic and male genital diseasesSeverity of Illness IndexCicatrixGermanyHumansMedicineCarotid StenosisParesthesiaEndarterectomy CarotidSkin incisionbusiness.industryGeneral Medicinefemale genital diseases and pregnancy complicationsSurgeryTreatment OutcomeFeasibility StudiesSurgeryCardiology and Cardiovascular MedicineComplicationbusinessAnesthesia LocalAnnals of Vascular Surgery
researchProduct

A new thrombectomy catheter device (AngioJet) for the disruption of thrombi: An in vitro study

1999

In this study we examined a new thrombectomy catheter device. Different kinds of in vitro generated thrombi and cadaver thrombi were disrupted in test tubes. The mean disruption rate (and disruption time for 1 g of thrombus) was 225 +/- 65 mg/sec (5 +/- 2 sec) for whole-blood, 117 +/- 60 mg/sec (12 +/- 9 sec) for fibrin, 41 +/- 18 mg/sec (30 +/- 18 sec) for mixed, 70 +/- 42 mg/sec (17 +/- 5 sec) for unorganized, 45 +/- 8 mg/sec (22 +/- 4 sec) for partly, and 5 +/- 1 mg/sec (216 +/- 29 sec) for completely organized cadaver thrombi (P0.05). More than 99% of fragmented particles of whole-blood thrombi were 0-12 microm in diameter. The particle size of fibrin, mixed, and cadaver thrombi was sim…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentIn Vitro TechniquesFibrinCatheterizationCadavermedicineHumansRadiology Nuclear Medicine and imagingParticle SizeThrombusThrombectomybiologybusiness.industryCatheter deviceThrombosisEquipment DesignGeneral MedicineThrombolysismedicine.diseaseThrombosisPulmonary embolismSurgerymedicine.anatomical_structureEmbolismbiology.proteinPulmonary EmbolismCardiology and Cardiovascular MedicineNuclear medicinebusinessArteryCatheterization and Cardiovascular Interventions
researchProduct

Nonroutine Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Complicating Myocardial Infarction With Successful and Unsuccessful Primary Percutan…

2018

Abstract Objectives The authors sought to compare outcomes of patients with myocardial infarction and cardiogenic shock (CS) treated with percutaneous coronary intervention (PCI) with or without intra-aortic balloon pump (IABP) support according to final epicardial flow in the infarct-related artery. Background A routine use of IABP is contraindicated in patients with myocardial infarction and CS. There are no data regarding the subpopulation of patients who may benefit from such support besides patients with mechanical complications of myocardial infarction. Methods Prospective nationwide registry data of patients with myocardial infarction and CS treated with PCI between 2003 and 2014 wer…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentShock Cardiogenicprimary PCI030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRisk FactorsInternal medicinemedicineHumansProspective StudiesRegistriescardiovascular diseases030212 general & internal medicineMyocardial infarctionIABPNon-ST Elevated Myocardial InfarctionIntra-aortic balloon pumpIntra-Aortic Balloon Pumpingbusiness.industryCardiogenic shockHazard ratiocardiogenic shockPercutaneous coronary interventionRecovery of FunctionThrombolysismedicine.diseaseTreatment Outcomesurgical procedures operativemyocardial infarctionConventional PCICardiologyST Elevation Myocardial InfarctionPolandCardiology and Cardiovascular MedicinebusinessTIMIJACC-Cardiovascular Interventions
researchProduct

Simultaneous cardiocerebral embolization in patients with atrial fibrillation

2020

medicine.medical_specialtyTime Factorsmedicine.medical_treatment[SDV]Life Sciences [q-bio]Myocardial Infarction030204 cardiovascular system & hematologyRisk AssessmentDecision Support Techniques03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineAtrial FibrillationIschaemic strokemedicineHumansThrombolytic TherapyIn patientMyocardial infarctionEmbolizationAngioplasty Balloon CoronaryIschemic StrokeThrombectomybusiness.industryAtrial fibrillationGeneral Medicinemedicine.diseaseCoronary embolismTreatment OutcomeIntracranial EmbolismConcomitantCardiologyStentsCardiology and Cardiovascular MedicinebusinessAlgorithms030217 neurology & neurosurgery
researchProduct